Talking about esophageal ultrasound-guided interventions for precordial disease

  In recent years, with the continuous progress of technology, the treatment of precardiac disease is becoming more and more minimally invasive, new techniques are emerging, and, due to the continuous accumulation of experience in diagnosis and treatment, the process of treating precardiac disease is causing less and less harm to patients. In the following, I will talk about the new technology of interventional treatment of precardiac disease under the guidance of ultrasound in the esophagus for patients and their families to understand and choose.  At present, the treatment methods for congenital heart disease can be divided into: a. Open-chest congenital disease correction under conventional extracorporeal circulation: this method is divided into axillary incision and median chest incision, suitable for all types of congenital heart disease, especially some complex congenital heart disease, the need for surgical treatment under extracorporeal circulation, the current method is relatively more traumatic, but also more mature and safe.  Second, non-extracorporeal circulation under surgical minimally invasive congenital heart disease intervention technology: this method is a new technology developed in the past ten years or so, with small incision, concealed, cosmetic, without extracorporeal circulation and blood transfusion, this method is adapted to common congenital heart disease of all ages, especially for some congenital heart disease that can not be completed through internal intervention methods can also be well completed.  Internal percutaneous interventional techniques:
This method has a better cosmetic effect on the treatment of common congenital heart disease and avoids surgical incision, but this method has certain disadvantages and limitations of application, which cannot be applied to younger children and special parts of congenital heart disease, and once the medical treatment fails, it needs to be urgently transferred to surgical treatment. In addition, radiation and contrast agent damage to the patient’s body is also a major disadvantage.  IV. Esophageal ultrasound-guided interventional treatment for precardiac disease.
With the continuous improvement of color ultrasound technology, in recent years, the interventional treatment technology of precardiac disease under ultrasound guidance has been developed rapidly, especially the percutaneous precardiac disease interventional treatment technology under ultrasound guidance, that is, avoiding surgical incisions, and avoiding the radiation and contrast agent damage to the patient’s body from percutaneous interventional treatment in internal medicine, especially for adolescents and adults with precardiac disease has great advantages over other methods.  The above are all the treatment methods for precocious heart disease, each of them has its advantages, disadvantages and indications, and patients and parents can choose according to the type of precocious heart disease.